Moomoo, why aren’t you reporting this FDA approval? Are you shorting it? NEWS came out at approximately 12PM ET so it is highly unlikely you didnt get the news.
“Arcutis Biotherapeutics Announces FDA Approval Of Supplemental New Drug Application For Zoryve (Roflumilast)
Cream 0.15% To Treat Mild To Moderate Atopic Dermatitis In Adults And Children 6 And Older” - Benzinga
Cream 0.15% To Treat Mild To Moderate Atopic Dermatitis In Adults And Children 6 And Older” - Benzinga
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Dennis Takizawa Hide : Are they allow to do that, withholding important informations? While other trading platform has already reported the approval for the FDA.
Jaguar8 OP Dennis Takizawa Hide : They can but is reportable
Mod Tanyatorn Jaguar8 OP : I will be wrinting to the press and see what's moomoo respond. I don't like the way they handle this. I will probably pivot to other trading app.
Jaguar8 OP Mod Tanyatorn : I don’t see approval on FDA. Looks like a leaked information